Coronavirus Disease 2019 (COVID-19): Exposure Risks, Diagnosis & Treatment

COVID-19 is the clinical syndrome produced when SARS-CoV-2 infects airway epithelium, replicates in the upper and lower tract, and triggers variable innate and adaptive immune responses. Viral entry exploits ACE2-rich tissues; beyond pneumocytes, endothelial activation and microthrombi explain why some patients develop myocardial injury, stroke, or renal hypoperfusion even when lung infiltrates appear modest on imaging.

Population immunity from vaccination and prior waves now attenuates aggregate severity in many regions, yet individuals—particularly older adults, those with cardiopulmonary comorbidity, or immunosuppressed hosts—still mount inflammatory lung responses severe enough to require high-flow oxygen, prone positioning, or intensive care. Nurses anchor safety by treating COVID-19 as a dynamic multisystem illness rather than a fixed “mild versus critical” label at admission.

Early illness mirrors other viral syndromes: coryzal symptoms, sore throat, headache, myalgia, and anosmia or dysgeusia in a subset. Gastrointestinal involvement (nausea, diarrhoea) appears more often with certain variants. Progressive pulmonary involvement adds tachypnoea, pleuritic discomfort, and hypoxaemia; some patients exhibit thrombotic events with minimal cough.

Immunocompromised hosts may shed virus longer, show subtler fever curves, or present with opportunistic superinfection rather than classic bilateral infiltrates. Children and young adults typically experience milder courses but remain candidates for observation when resting hypoxia, dehydration, or concerning pain develops.

SARS-CoV-2 is a betacoronavirus within the same phylogenetic neighbourhood as the viruses responsible for SARS and some zoonotic reservoirs. Humans acquire infection through inhalation of droplets and aerosols, close contact exposures, and occasionally fomites—prevention therefore layers ventilation, masking in outbreak contexts, vaccination, and prompt case isolation.

Non-modifiable risks include older age and male sex in many cohorts; modifiable or care-oriented risks include obesity, diabetes, chronic kidney disease, chronic hypoxic lung disease, and immunosuppressive therapy. Healthcare exposure remains relevant where community prevalence climbs; occupational health tracks booster timing and fit-tested respiratory protection for aerosol-generating procedures.

Frameworks emphasise oxygen requirement, respiratory system compliance, and perfusion rather than relying on PCR cycle thresholds alone. Many hospitals embed early warning scores—pair numeric risk with qualitative nurse concern because both jointly predict unplanned ICU transfer.

↔On a small screen, swipe or scroll sideways to see the full table.

Clinical assessment

Fuse history (exposure, symptom timeline, prior vaccines) with structured respiratory assessment, work of breathing, mentation, and baseline functional status. Screen for pregnancy, anticoagulation, and drug interactions before committing to antiviral pathways.

Laboratory investigations

CRP, D-dimer, troponin, renal panel, and CBC trends help risk-stratify inpatients and differentiate inflammatory surges from bacterial co-infection. Lactate forms part of sepsis bundles when perfusion is questioned.

Imaging

Chest radiograph often shows bilateral peripheral opacities but may be near normal early; CT reserved for selected complications. Point-of-care ultrasound appears in some services for pleural effusion or line placement but never replaces guideline-directed oxygen titration.

Microbiologic confirmation

Nucleic acid amplification tests from nasal or oropharyngeal swabs remain reference standard for many public-health uses; antigen tests trade sensitivity for speed. Document collection quality and time since symptom onset when results seem discordant with the bedside picture.

• Influenza (flu) and other respiratory viruses—coinfection occurs; oseltamivir decisions follow local microbiology timing.
• Common cold illnesses—shorter febrile peaks and absent hypoxia, but early COVID may mimic.
• Community-acquired bacterial pneumonia—purulent sputum, focal consolidation, procalcitonin context.
• Pulmonary embolism—pleuritic pain, tachycardia, hypoxia with relatively clear auscultation.
• Non–COVID-19 ARDS from aspiration, pancreatitis, or massive transfusion—history and imaging angles differ.

First-line inpatient pillars

• Supplemental oxygen to institution-specific saturation targets with escalation readiness—nurses execute oxygen therapy orders and escalate early if targets slip.
• Systemic corticosteroids for hospitalised patients meeting oxygen thresholds; monitor glycaemia and mood changes.
• Pharmacologic VTE prophylaxis unless contraindicated; switch to mechanical devices when platelets crater or active bleeding emerges.

Antivirals and immunomodulators

Oral antivirals suit selected outpatients with symptom duration and risk factors within product labels; monoclonals and kinase inhibitors occupy narrower niches as variants shift susceptibility. IL-6 pathway inhibitors (where available) require infection surveillance and glucose checks because superinfection and hyperglycaemia complicate recovery.

Supportive and critical care

Includes prone ventilation, paralysis sparing protocols, renal replacement, and neuroprotective sedation plans. Nutrition, pressure-injury mitigation, and delirium bundles run in parallel—COVID-19 ICU length of stay rewards meticulous basic nursing science.

Special populations

Pregnancy merits fetal monitoring coordination; renal impairment demands dose adjustment of antivirals and low-molecular-weight heparin; solid-organ transplant recipients need MDT decisions on immunosuppression modulation—always cite local consensus, not anecdote.

• Monitoring cadence: Minimum 4-hourly observations for ward inpatients unless early warning scores dictate hourly sets; reassess within 30–60 minutes after each oxygen titration change.
• Treatment failure: Worsening oxygen requirement after 48–72 hours on maximal appropriate therapy, new focal lung signs, or rising procalcitonin should trigger senior review for secondary infection or imaging.
• Follow-up: Discharged hypoxic patients often merit community oxygen services within 24–48 hours plus primary-care review at 1–2 weeks for persistent dyspnoea or mental health sequelae.
• Drug–drug vigilance: Some oral antivirals interact with calcineurin inhibitors and statins—pharmacist reconciliation before administration prevents iatrogenic harm.
• MDT roles: Physiotherapists lead proning and secretion clearance; pharmacists steer corticosteroid bridging; specialty nurses coordinate anticoagulation clinics when extended prophylaxis is planned.

Bedside monitoring checklist

• SpO₂ trend, device fit, and patient-specific target range.
• Respiratory rate, accessory muscle use, ability to complete sentences.
• Urine output, creatinine, potassium after fluid shifts or diuretics.
• Calf asymmetry, sudden chest pain, or unexplained syncope—PE flags.

• Bacterial pneumonia and ventilator-associated pneumonia prolong ventilation; escalate cultures before blind antibiotic escalation in every case.
• VTE and stroke despite prophylaxis—maintain high index of suspicion when neuro deficits appear.
• Acute kidney injury from cytokine-mediated hypoperfusion, rhabdomyolysis, or nephrotoxic drugs.
• Post–COVID-19 fatigue, autonomic symptoms, and neurocognitive fog—requires structured rehab referral, outside the scope of acute wards but must appear in discharge letters.

Multicomponent prevention couples up-to-date vaccination (primary series plus boosters per local programme), ventilation improvements in congregate settings, prompt testing of siblings, and work restrictions for febrile staff. Hospital prevention adds PPE for AGPs, single rooms or cohorting when surge capacity forces compromises, and rigorous environmental cleaning of high-touch zones.

Most vaccinated younger adults recover within 2–3 weeks; persistent symptoms warrant primary-care longitudinal clinics. Hospitalised survivors face elevated risks of cardiac and thrombotic events for months—document smoking cessation, statin adherence, and mental-health referrals before closing the electronic discharge summary.

Communication

Use teach-back for home oximetry: patients must know when to call emergency services if SpO₂ drops below their personalised threshold or if lips and fingers cyanose despite normal temperature.

Medication safety

Double-check insulin sliding scales when steroids raise glucose; reconcile anticoagulant holds whenever procedures land on the day.

Documentation

Record oxygen device, flow rate, and target saturation every shift; note prone sessions and skin checks—medicolegal reviews after rapid response events lean heavily on this nursing granularity.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of COVID-19 recognition, structured oxygen / dexamethasone / antiviral / IL-6 / IL-1 / JAK pathway, infection prevention and the silent-hypoxaemia / ARDS / VTE / cardiac / paediatric MIS-C / long-COVID red flags.